Shares of Propanc Biopharma, Inc. (OTCMKTS:PPCB – Get Free Report) were up 108.3% during mid-day trading on Thursday . The stock traded as high as $145.46 and last traded at $25.00. Approximately 753 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 11,821,764 shares. The stock had previously closed at $12.00.
Propanc Biopharma Trading Up 11.1 %
The stock’s 50-day simple moving average is $0.68 and its 200 day simple moving average is $0.24.
Propanc Biopharma Company Profile
Propanc Biopharma, Inc, a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.
Read More
- Five stocks we like better than Propanc Biopharma
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Propanc Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Propanc Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
